Insider Transactions in Q1 2021 at Kindred Biosciences, Inc. (KIN)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 17
2021
|
Denise Bevers Director |
SELL
Open market or private sale
|
Indirect |
8,396
-100.0%
|
$41,980
$5.0 P/Share
|
Mar 17
2021
|
Denise Bevers Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
8,396
+50.0%
|
$0
$0.32 P/Share
|
Feb 22
2021
|
Denise Bevers Director |
SELL
Open market or private sale
|
Indirect |
4,622
-100.0%
|
$23,110
$5.0 P/Share
|
Feb 22
2021
|
Denise Bevers Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,622
+50.0%
|
$0
$0.32 P/Share
|
Feb 19
2021
|
Denise Bevers Director |
SELL
Open market or private sale
|
Indirect |
5
-100.0%
|
$25
$5.0 P/Share
|
Feb 19
2021
|
Denise Bevers Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
5
+50.0%
|
$0
$0.32 P/Share
|
Feb 01
2021
|
Richard Chin Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,582
-0.33%
|
$32,910
$5.0 P/Share
|
Feb 01
2021
|
Richard Chin Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+0.63%
|
-
|
Jan 29
2021
|
Park West Asset Management LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,300
-0.05%
|
$16,500
$5.07 P/Share
|
Jan 28
2021
|
Park West Asset Management LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
210,472
-3.18%
|
$1,052,360
$5.25 P/Share
|
Jan 23
2021
|
Richard Chin Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,163
-0.66%
|
$52,652
$4.93 P/Share
|
Jan 23
2021
|
Hangjun Zhan Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,385
-7.93%
|
$13,540
$4.93 P/Share
|
Jan 23
2021
|
Wendy Wee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,385
-6.46%
|
$13,540
$4.93 P/Share
|
Jan 22
2021
|
Richard Chin Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,744
-0.99%
|
$78,976
$4.93 P/Share
|
Jan 22
2021
|
Richard Chin Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+1.84%
|
-
|
Jan 22
2021
|
Hangjun Zhan Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,385
-7.35%
|
$13,540
$4.93 P/Share
|
Jan 22
2021
|
Hangjun Zhan Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+11.94%
|
-
|
Jan 22
2021
|
Wendy Wee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,062
-7.19%
|
$16,248
$4.93 P/Share
|
Jan 22
2021
|
Wendy Wee Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+11.72%
|
-
|
Jan 17
2021
|
Hangjun Zhan Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,385
-7.83%
|
$13,540
$4.95 P/Share
|
Jan 17
2021
|
Hangjun Zhan Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+12.64%
|
-
|
Jan 17
2021
|
Wendy Wee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,385
-6.47%
|
$13,540
$4.95 P/Share
|
Jan 17
2021
|
Wendy Wee Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+10.66%
|
-
|
Jan 17
2021
|
Richard Chin Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,128
-1.06%
|
$84,512
$4.95 P/Share
|
Jan 17
2021
|
Richard Chin Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+1.85%
|
-
|
Jan 14
2021
|
Denise Bevers Director |
SELL
Open market or private sale
|
Indirect |
13,023
-100.0%
|
$65,115
$5.0 P/Share
|
Jan 14
2021
|
Denise Bevers Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
13,023
+50.0%
|
$0
$0.32 P/Share
|
Jan 07
2021
|
Denise Bevers Director |
SELL
Open market or private sale
|
Indirect |
39,069
-100.0%
|
$195,345
$5.0 P/Share
|
Jan 07
2021
|
Denise Bevers Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
39,069
+43.81%
|
$0
$0.32 P/Share
|